A study to observe patients characteristics, treatment patterns and outcomes in patients with newly diagnosed breast cancer in Latin America.
Type of Study: Epidemiological
Sponsor / Support: LACOG, Roche
Primary Objectives: To prospectively describe patients’ characteristics and breast cancer subtypes at diagnosis in Latin America; To prospectively describe treatment patterns and outcomes in HER2 positive and other breast cancer subtypes in Latin America; To build an electronic platform/database to allow collection of epidemiological data on breast cancer patients in Latin America;
Design: Prospective, multicenter, analytical, non-interventional study of secondary data use.
Sample Size: 4.500 patients
Principal Investigator: Gustavo Werutsky
Countries LATAM: Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica, Cuba, Ecuador, Guatemala, Mexico, Peru, Republica Dominicana, Uruguay and Venezuela
LACOG 1518 – Bladder Cancer Registry
LACOG 0515 – Testicular Registry
LACOG 0217 – IRONMAN
LACOG 1818 – Prostate Cancer Registry
LACOG 0218 – Hercules
LACOG 0415 – APA in Prostate Cancer
LACOG 0519 – PEACE III